March, 2021 , The Medicine Maker
Technology transfer is full of risks. But risks can be mitigated with the right strategy and help from digital technologies
By: Alan Steven
February, 2021 , The Medicine Maker
Speed and efficiency are everything in pharmaceutical synthesis – and that’s why biocatalysis is an increasingly attractive option
By: Alice Dunbabin
January, 2021 , The Small Molecule Manufacturer
Alan Steven explains why environmental sustainability and “big picture thinking” should be key considerations when selecting solvents for scale-up
November, 2020 , The Medicine Maker
Our CEO, Dr Ross Burn talks about surviving and thriving as a new company focused on process chemistry, alongside more recent moves into industry 4.0 and collaborations in the contract research space
By: Ross Burn
September, 2020 , Chemistry Today
Our Chief Operating Officer, Dr Simon Tyler participated in the latest Chemistry Today panel discussion on custom synthesis and contract manufacturing
By: Simon Tyler
July, 2020 , Chemistry Today
Our Associate Principal Scientist, Dr Vargini Thangavadivale participated in the latest Chemistry Today panel discussion on catalysis
By: Vargini Thangavadivale
July, 2020 , Mantell Associates Network
Our CEO, Dr Ross Burn spoke to the Mantell Associates Network podcast about innovation during the COVID-19 pandemic
June, 2020 , The Medicine Maker
Our Chief Operating Officer, Dr Simon Tyler, recently spoke with The Medicine Maker to discuss the continuing impacts of COVID-19 on the pharmaceutical industry
June, 2020 , Chemicals Knowledge Hub
Our CEO, Dr Ross Burn talked to Chemicals Knowledge Hub TV about the origins of CatSci, our strategic shift and exponential growth over the past few years.
April, 2020 , CHEManager International
Our Head of Business Development for North America, Dr Jas Douville, recently spoke to CHEManager International about how a CRO can succeed in the global marketplace.
By: Jas Douville
